Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Targeting the PGI2 pathway may help heal diabetic foot ulcers.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

Prostaglandin F2alpha and related compounds can increase hair growth and darken hair in mice.

Prostaglandin D2 increases testosterone levels in skin cells through reactive oxygen species, not enzymes, which could lead to new hair loss treatments.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Blocking certain brain processes reduces mating behavior in female rats.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Prostaglandin helps regenerate hair follicles after radiation damage.

A new treatment for hair loss shows promise with fewer side effects.

Higher levels of the DP2 receptor may lead to hair loss.

Progesterone affects GABA_A receptor function by altering δ subunit levels.

GPR40 agonists help hair growth through the protein ANGPTL4.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.